Targeting AXL can effectively overcome c-Met-induced therapeutic resistance in renal cancer and promote tumor cell death through increased oxidative stress
Published in Cancer Letters, 2025
Recommended citation: Sabarwal A, Machaalani M, Rawat L, Wedel J, Tabasum S, Sasamoto Y, Buerger F, Ascione J, Eid M, Semaan K, Saad E, Yang Y, Lee D, Hodi FS, Freedman ML, Lee GSM, Balan M, Choueiri TK, Pal S. Targeting AXL can effectively overcome c-Met-induced therapeutic resistance in renal cancer and promote tumor cell death through increased oxidative stress. Cancer Lett. 2025;633:217984. doi:10.1016/j.canlet.2025.217984.
View Paper